News

600,000 Euro Seed Funding Dutch Biotech Coating Startup

Nanotechnology Seed Investment

Fabian Stein
July 13, 2017
LipoCoat announces 600,000 euro seed funding for medical coating development

Introduction

LipoCoat BV, a spin-off from the MESA+ institute at University of Twente, gathered €600,000 in seed funding. 600,000 Euro Seed FundingLipoCoat BV secured €600,000 with grants, a Redmedtech Ventures loan, and investments from LLX2.
600,000 Euro Seed FundingLipoCoat BV secured €600,000 with grants, a Redmedtech Ventures loan, and investments from LLX2. The funds accelerate early product development for biocompatible medical coatings.
Updates

Also interesting

Mockup of the LipoCoat technology brochure
Document

A coating inspired by the cell membrane: LipoCoat® in three applications

LipoCoat® is a 5 nm phospholipid coating that stops proteins and bacteria from adhering. The new technology brochure shows how it performs on catheters, contact lenses and needles, and how it fits your production line.

Lipocoat team celebrating the company's 10th anniversary
News

Lipocoat Group celebrates its 10th anniversary and breaks ground on a new production lab in Enschede.

Lipocoat Group is building a 500-square-meter production lab across from the University of Twente and is marking its tenth anniversary. Constantijn van Oranje started construction.

Ultrasound-guided needle procedure with a SonoCoat coated needle
Publication

SonoCoat® Technology Featured in Scientific Publications

Four independent peer-reviewed studies have evaluated SonoCoat®, from EUS-FNA needles to prostate brachytherapy. What each one tested, and what it found.